Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

Strengths
Adalimumab 40 mg/.4mL; Adalimumab 40 mg/.8mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Adalimumab 10 mg/.1mL; Adalimumab 10 mg/.2mL; Adalimumab 20 mg/.4mL
Dosage forms
Injection, Solution, Injection, Solution
Routes
Subcutaneous
Drug classes (FDA established)
Tumor Necrosis Factor Blocker
Package NDCs
65

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Adalimumab NDC Codes: finished products
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)HCPCS
Adalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousCordavis Limited83457-18683457-0186-01J0135
Adalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousCordavis Limited83457-18783457-0187-01J0135
Adalimumabadalimumab-adazAdalimumab 10 mg/.1mLInjection, SolutionSubcutaneousSandoz Inc61314-39161314-0391-64J0135
Adalimumabadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousSandoz Inc61314-32561314-0325-20J0135
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousNuvaila Limited84612-39984612-0399-01J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousNuvaila Limited84612-47984612-0479-0184612-0479-02J0135
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousNuvaila Limited84612-48184612-0481-0184612-0481-02J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousNuvaila Limited84612-48284612-0482-0184612-0482-02J0135
Adalimumabadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousSandoz Inc61314-33261314-0332-64J0135
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousAmgen USA Inc.72511-39972511-0399-01J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen USA Inc.72511-47972511-0479-02J0135
Hyrimozadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-10783457-0107-01J0135
Hyrimozadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousCordavis Limited83457-10883457-0108-01J0135
Hyrimozadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-11383457-0113-01J0135
Hyrimozadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousCordavis Limited83457-10083457-0100-01J0135
Hyrimozadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousCordavis Limited83457-10183457-0101-01J0135
Hyrimozadalimumab-adazAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-10283457-0102-01J0135
Hyrimozadalimumab-adazAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousCordavis Limited83457-10383457-0103-01J0135
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousAmgen, Inc55513-39955513-0399-01J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-47955513-0479-0155513-0479-02J0135
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-48055513-0480-0155513-0480-02J0135
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-48155513-0481-0155513-0481-02J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-48255513-0482-0155513-0482-02J0135
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen USA Inc.72511-48172511-0481-02J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen USA Inc.72511-48272511-0482-0172511-0482-02J0135
Adalimumabadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousSandoz Inc61314-32761314-0327-2061314-0327-64J0135
Hyrimozadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousSandoz Inc61314-45461314-0454-2061314-0454-3661314-0454-68J0135
Hyrimozadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousSandoz Inc61314-47361314-0473-2061314-0473-6461314-0473-92J0135
Hyrimozadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousSandoz Inc61314-47661314-0476-64J0135
Hyrimozadalimumab-adazAdalimumab 10 mg/.1mLInjection, SolutionSubcutaneousSandoz Inc61314-50961314-0509-64J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousA-S Medication Solutions50090-670550090-6705-00J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousA-S Medication Solutions50090-670650090-6706-00J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousA-S Medication Solutions50090-670750090-6707-00J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousOrganon LLC78206-18378206-0183-01J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousOrganon LLC78206-18478206-0184-01J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousOrganon LLC78206-18578206-0185-01J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousOrganon LLC78206-18678206-0186-01J0135
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousOrganon LLC78206-18778206-0187-0178206-0187-59J0135
Yusimryadalimumab-aqvhAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.71288-81571288-0815-81J0135
Yusimryadalimumab-aqvhAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.71288-81671288-0816-81J0135
Yusimryadalimumab-aqvhAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousCoherus BioSciences Inc70114-21070114-0210-02J0135
Yusimryadalimumab-aqvhAdalimumab 40 mg/.8mLInjection, SolutionSubcutaneousCoherus BioSciences Inc70114-22070114-0220-02J0135
Amjevitaadalimumab-attoAdalimumab 10 mg/.2mLInjectionSubcutaneousAmgen, Inc55513-41355513-0413-01J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-40055513-0400-0155513-0400-0255513-0400-91J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-41055513-0410-0155513-0410-02J0135
Amjevitaadalimumab-attoAdalimumab 20 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-41155513-0411-01J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen USA Inc.72511-40072511-0400-0172511-0400-02J0135

Adalimumab: common questions

Which drugs contain Adalimumab?
Amjevita, Hyrimoz, Hadlima, Adalimumab, Yusimry, Adalimumab-bwwd.
Is there a J-code for Adalimumab?
Med-Code's HCPCS directory matches J0135 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Adalimumab NDC Codes | National Drug Code Directory | Med-Code